Medicure Inc. (OTCMKTS:MCUJF – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.63 and traded as low as $0.50. Medicure shares last traded at $0.50, with a volume of 500 shares traded.
Medicure Price Performance
The company has a quick ratio of 1.64, a current ratio of 2.03 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $5.21 million, a price-to-earnings ratio of -3.57 and a beta of 0.87. The stock’s 50 day moving average price is $0.52 and its two-hundred day moving average price is $0.63.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Stories
- Five stocks we like better than Medicure
- Want to Profit on the Downtrend? Downtrends, Explained.
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Why Are These Companies Considered Blue Chips?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
